Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis - PubMed (original) (raw)
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Chantal A Rivera et al. J Hepatol. 2007 Oct.
Abstract
Background/aims: Studies in animal models and humans suggest a link between endotoxemia and non-alcoholic steatohepatitis. Since Kupffer cells are responsible for clearing endotoxin and are activated via endotoxin interaction with Toll-like receptor 4 (TLR-4), we examined the relationship between hepatic TLR-4 expression and Kupffer cell content during the genesis of steatohepatitis.
Methods: Male C57BL/6, C3H/HouJ and TLR-4 mutant C3H/HeJ mice were fed control or methionine/choline-deficient diet (MCDD). In one group of C57BL/6 mice, Kupffer cells were depleted by weekly intraperitoneal injections of clodronate liposomes. After 3 weeks, serum ALT activity and portal endotoxin levels were measured. Real-time PCR was used to examine mRNA expression of TLR-4, TLR-2, CD14, MD-2, TGFbeta, TNFalpha, CD36, PPAR-alpha, liver fatty acid binding protein (L-FABP) and collagen alpha1.
Results: We observed histological evidence typical of steatohepatitis, portal endotoxemia and enhanced TLR-4 expression in wild type mice fed MCDD. In contrast, injury and lipid accumulation markers were significantly lower in TLR-4 mutant mice. Destruction of Kupffer cells with clodronate liposomes blunted histological evidence of steatohepatitis and prevented increases in TLR-4 expression.
Conclusions: These findings demonstrate the importance of TLR-4 signaling and underscore a direct link between TLR-4 and Kupffer cells in the pathogenesis of steatohepatitis.
Figures
Figure 1. Effect of feeding MCDD on TLR-4 signaling molecules
(A) For assessment of TLR-4, MD2 and CD14 expression, livers were collected from male C57BL/6 mice fed CD or MCDD for 3 weeks. Pre-developed assays for real-time PCR were used according to the manufacturer’s instructions (Applied Biosystems). Expression of each target mRNA was calculated relative to average values in the control group using a comparative CT method and presented as mean ± SEM of at least 4 observations/group. (B) Western blot analysis of hepatic TLR-4 expression relative to β-actin was used to confirm enhanced protein levels. Values are mean ± SEM of at least 4 observations per group. *p< 0.05, **p< 0.005 compared to control using Student’s t test.
Figure 2. Hepatic Histopathology
Representative H&E-stained photomicrographs of (A) C3H/HouJ + CD; (B)) C3H/HeJ + CD (C)) C3H/HouJ + MCDD (D) C3H/HeJ + MCDD; endotoxin sensitive (left panels) mice fed MCDD display obvious NASH. Injury was clearly diminished in endotoxin resistant mice (right panels). Additional sections of liver from mice fed MCDD were subjected to immunohistochemical staining for neutrophils (E&F) and Kupffer cells (F4/80; G&H). The appearance of brown staining indicates the presence of these cells in response to MCDD.
Figure 3. Hepatic triglyceride content and serum ALT activity
Serum levels of the liver-specific injury marker ALT (A) and triglyceride levels (B) in 20% liver homogenates were measured using standard spectrophotometric assays. Statistical comparisons were made using two-way ANOVA. *p< 0.05 compared to PBS controls or #diet-matched C3H/HouJ mice.
Figure 4. Hepatic PPAR-αand L-FABP expression
Expression of PPAR-α and L-FABP mRNA was analyzed by real-time PCR and calculated relative to average values in the control group using a comparative CT method. Data are presented as mean ± SEM of 5 observations/group. Statistical comparisons were made using two-way ANOVA. *p< 0.05 compared to PBS controls or #diet-matched C3H/HouJ mice.
Figure 5. TNF-α and Collagen mRNA in C3H/HeJ mice
Expression of TNF-α and Collagen α1 mRNA was analyzed by real-time PCR and calculated relative to average values in the control group using a comparative CT method. Data are presented as mean ± SEM of 5 observations/group. Statistical comparisons were made using two-way ANOVA. *p< 0.05 compared to PBS controls or #diet-matched C3H/HouJ mice.
Figure 6. Effect of clodronate liposomes on Kupffer cells
To confirm destruction of Kupffer cells, livers of mice fed control diet or MCDD were preserved in zinc fixative and subjected to immunohistochemical staining with primary antibodies directed against macrophages (F4/80). Hematoxylin was used as a counter stain. Positive cells are stained brown. Photomicrographs are representative of 6 mice/dietary group.
Figure 7. Hepatic expression of (A) TNF-α, (B) TGF-β and (C) Collagen
Livers were collected from male C57BL/6 mice fed control (CD) or methionine/choline deficient (MCDD) for 3 weeks. In addition, mice were administered clodronate liposomes (200 µg/mouse) to destroy Kupffer cells or PBS (phosphate-buffered saline) as a vehicle control as described in Methods. Pre-developed assays for real-time PCR were used to assess target mRNA levels. Statistical comparisons were made using two-way ANOVA (n= 5/group). *p< 0.05 compared to mice fed control diet; #diet-matched PBS (phosphate-buffered saline) controls.
Figure 8. Effect of Kupffer cell destruction on toll-like receptor expression
After 3 weeks of feeding MCDD the effect of Kupffer cell destruction on expression of TLR-4, CD36 and TLR-2 was examined using real-time PCR. Statistical comparisons were made using two-way ANOVA (n= 5/group). *p< 0.05 compared to mice fed control diet or #p< 0.05 compared to diet-matched PBS (phosphate-buffered saline) controls.
Similar articles
- Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
Rivera CA, Gaskin L, Allman M, Pang J, Brady K, Adegboyega P, Pruitt K. Rivera CA, et al. BMC Gastroenterol. 2010 May 28;10:52. doi: 10.1186/1471-230X-10-52. BMC Gastroenterol. 2010. PMID: 20509914 Free PMC article. - Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I. Spruss A, et al. Hepatology. 2009 Oct;50(4):1094-104. doi: 10.1002/hep.23122. Hepatology. 2009. PMID: 19637282 - Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. Larter CZ, et al. J Gastroenterol Hepatol. 2008 Feb;23(2):267-75. doi: 10.1111/j.1440-1746.2007.05157.x. Epub 2007 Sep 12. J Gastroenterol Hepatol. 2008. PMID: 17868330 - Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
Baffy G. Baffy G. J Hepatol. 2009 Jul;51(1):212-23. doi: 10.1016/j.jhep.2009.03.008. Epub 2009 Mar 31. J Hepatol. 2009. PMID: 19447517 Free PMC article. Review. - Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.
Roh YS, Seki E. Roh YS, et al. J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1(0 1):38-42. doi: 10.1111/jgh.12019. J Gastroenterol Hepatol. 2013. PMID: 23855294 Free PMC article. Review.
Cited by
- The multifaceted roles of B lymphocytes in metabolic dysfunction-associated steatotic liver disease.
Li H, Xia N. Li H, et al. Front Immunol. 2024 Sep 20;15:1447391. doi: 10.3389/fimmu.2024.1447391. eCollection 2024. Front Immunol. 2024. PMID: 39372417 Free PMC article. Review. - Impact of gut microbiota on metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma: pathways, diagnostic opportunities and therapeutic advances.
Kumar AR, Nair B, Kamath AJ, Nath LR, Calina D, Sharifi-Rad J. Kumar AR, et al. Eur J Med Res. 2024 Oct 5;29(1):485. doi: 10.1186/s40001-024-02072-3. Eur J Med Res. 2024. PMID: 39367507 Free PMC article. Review. - Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation.
Yanagisawa H, Maeda H, Noguchi I, Tanaka M, Wada N, Nagasaki T, Kobayashi K, Kanazawa G, Taguchi K, Chuang VTG, Sakai H, Nakashima H, Kinoshita M, Kitagishi H, Iwakiri Y, Sasaki Y, Tanaka Y, Otagiri M, Watanabe H, Maruyama T. Yanagisawa H, et al. Redox Biol. 2024 Oct;76:103314. doi: 10.1016/j.redox.2024.103314. Epub 2024 Aug 17. Redox Biol. 2024. PMID: 39163766 Free PMC article. - Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease : Pediatric Fatty Liver and Probiotics.
Nicastro E, D'Antiga L. Nicastro E, et al. Adv Exp Med Biol. 2024;1449:113-133. doi: 10.1007/978-3-031-58572-2_7. Adv Exp Med Biol. 2024. PMID: 39060734 Review. - HDAC6 inhibitor ACY-1215 protects from nonalcoholic fatty liver disease via inhibiting CD14/TLR4/MyD88/MAPK/NFκB signal pathway.
Fu S, Xu M, Li J, Yu M, Wang S, Han L, Li R, Deng F, Peng H, Liu D, Tan Y. Fu S, et al. Heliyon. 2024 Jun 27;10(13):e33740. doi: 10.1016/j.heliyon.2024.e33740. eCollection 2024 Jul 15. Heliyon. 2024. PMID: 39055804 Free PMC article.
References
- Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol Gastrointest Liver Physiol. 2001 Aug;281(2):G382–G392. - PubMed
- Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatol. 2003 Feb;37(2):343–350. - PubMed
- Vanderhoof JA, Metz MJ, Tuma DJ, Antonson DL, Sorrell MF. Effect of improved absorption on development of jejunoileal bypass- induced liver dysfunction in rats. Dig Dis Sci. 1980 Aug;25(8):581–586. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01 HL084723/HL/NHLBI NIH HHS/United States
- 1K01HL084723-01/HL/NHLBI NIH HHS/United States
- K01 HL084723-01/HL/NHLBI NIH HHS/United States
- P01 DK043785/DK/NIDDK NIH HHS/United States
- 3P01DK43785-13S1/DK/NIDDK NIH HHS/United States
- P01 DK043785-14S1/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials